BioArmour™ Advanced Wound Care

Biovation’s BioArmour™ Advanced Wound Care (AWC) dressing addresses a substantial gap in the current wound care market. The unique hybrid product combines the performance and benefit features of foam, hydrogel, alginate, hydrocolloid and gauze in a cost effective and efficacious platform.

Composed of a gel-cast biopolymer matrix, the BioArmour™ AWC dressing incorporates wound healing actives. Also contained within the gel-cast biopolymer matrix is a controlled and sustained release antimicrobial agent to protect and prevent infection of the wound bed. The biopolymer matrix allows for quick wicking and control of exudate while maintaining an adequate moisture level for rapid healing of the wound. The flexibility and non-adherent properties of the dressing provides patient comfort during dressing changes.

Under the supervision of a healthcare professional, BioArmour™ Advanced Wound Care Dressing will be indicated for use in light to moderate exuding partial and full thickness wounds including decubitus ulcers, diabetic ulcers, 1st and 2nd degree burns, and donor sites. This dressing may also be used over debrided and partial thickness wounds.

  • Cost-effective
  • Efficacious
  • Ease of use
  • Does not disintegrate when cut, during use or when removed.
  • Offered as a roll to healthcare professionals.
  • Product cut to size.
  • Product is 100% sustainable and green.
Enhanced Patient Comfort & Safety
  • Integrated wound healing agents to gel-cast matrix.
  • Flexible, soft and requires no pre-wettings.
  • Maintains a moist environment.
  • Non-adherent to wound bed.
  • Extremely low risk of skin irritation and sensitization; high comfort level.
Advanced Absorbency Capabilities
  • Capable of 50-60 g/100cm2 absorption.
  • “Gel-lock” of exudate.
  • For low to moderately exuding wounds.
Optimized Antimicrobial Performance
  • Our system is custom formulated for prompt and persistent release of silver ions.
  • The silver ions are contained within the gel-cast biopolymer matrix.
  • Silver-Ions are freely and readily available via (a) controlled release mechanism(s).
  • Provides a 2 to 4-log (99.99%) reduction in the 24 hr. time period for a multiplicity of pathogens (MRSA, A. baumannii, et. al).
  • Contains levels of silver 10× lower than industry leaders/benchmarks.

The two most important functions of surgical or wound dressings are 1) the ability to absorb and hold fluid and 2) the ability to quickly wick and maintain a critical moisture balance of the wound bed to avoid maceration of newly formed tissue and drying or scabbing of the wound.  The wound dressing should be soft, comfortable and conforming to the wound to ensure optimal performance and maximum patient comfort.  In addition, the dressing should release easily from the wound so that the removal of the dressing does not damage the fragile, newly formed tissue.

To further our goals in providing solutions for the wound care market we have developed a manufacturing methodology that we refer to as gel-cast biopolymer matrix which results in a new wound healing absorbent dressing composed of fibers and materials that have inherently low bioburden. The gel-cast biopolymer dressing has the capability to deliver non-toxic antimicrobial agents for infection control properties, with full bio-compatibility. The dressing is non-adherent to body tissue. This novel absorbent dressing has other advantages such as: high mechanical wet strength in the wound bed, easy conformability to the wound, and a pliable and flexible structure with no sharp edges that can cause pressure and stress in the wound. Even in the event the dressing is cut to shape, there are no sharp edges or material that can disassociate from the dressing and reside in the wound causing a secondary infection site.

We are currently engaged in FDA testing and evaluation for 510(k) certification and registration. For select partners, key opinion leaders and customers, non-commercial samples can be provided. We look forward to engaging with you and your team.